CN1034504C - 硫代烷硫基头孢菌素的制备方法 - Google Patents

硫代烷硫基头孢菌素的制备方法 Download PDF

Info

Publication number
CN1034504C
CN1034504C CN91104905A CN91104905A CN1034504C CN 1034504 C CN1034504 C CN 1034504C CN 91104905 A CN91104905 A CN 91104905A CN 91104905 A CN91104905 A CN 91104905A CN 1034504 C CN1034504 C CN 1034504C
Authority
CN
China
Prior art keywords
compound
ethyl acetate
het
added
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN91104905A
Other languages
English (en)
Chinese (zh)
Other versions
CN1058595A (zh
Inventor
久保田忠俊
粂昌治
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of CN1058595A publication Critical patent/CN1058595A/zh
Application granted granted Critical
Publication of CN1034504C publication Critical patent/CN1034504C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN91104905A 1990-07-19 1991-07-19 硫代烷硫基头孢菌素的制备方法 Expired - Fee Related CN1034504C (zh)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP191889/90 1990-07-19
JP19188990 1990-07-19
JP289772/90 1990-10-25
JP28977290 1990-10-25
JP319578/90 1990-11-21
JP31957890 1990-11-21
JP14735791 1991-06-19
JP147357/91 1991-06-19

Publications (2)

Publication Number Publication Date
CN1058595A CN1058595A (zh) 1992-02-12
CN1034504C true CN1034504C (zh) 1997-04-09

Family

ID=27472779

Family Applications (1)

Application Number Title Priority Date Filing Date
CN91104905A Expired - Fee Related CN1034504C (zh) 1990-07-19 1991-07-19 硫代烷硫基头孢菌素的制备方法

Country Status (22)

Country Link
US (2) US5214037A (pt)
EP (2) EP0594263B1 (pt)
JP (1) JP2618119B2 (pt)
KR (1) KR100203726B1 (pt)
CN (1) CN1034504C (pt)
AT (2) ATE181066T1 (pt)
AU (1) AU634074B2 (pt)
CA (2) CA2359026A1 (pt)
DE (2) DE69103490T2 (pt)
DK (2) DK0467647T3 (pt)
ES (1) ES2062688T3 (pt)
FI (1) FI110322B (pt)
HU (2) HU222727B1 (pt)
IE (1) IE65926B1 (pt)
IL (1) IL98745A (pt)
MX (1) MX9100227A (pt)
NO (1) NO178544C (pt)
NZ (1) NZ238838A (pt)
PH (1) PH31091A (pt)
PL (3) PL167099B1 (pt)
PT (1) PT98362B (pt)
RU (2) RU2071963C1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100576A (en) * 1991-01-18 1995-11-27 Eli Lilley And Company Cephalosporin antibiotics
EP0581552B1 (en) * 1992-07-31 1998-04-22 Shionogi & Co., Ltd. Triazolylthiomethylthio cephalosporin hyrochloride, its crystalline hydrate and the production of the same
JP3238209B2 (ja) * 1992-09-30 2001-12-10 塩野義製薬株式会社 チオメチルチオカルバセファロスポリン誘導体
KR100377559B1 (ko) * 1998-08-31 2003-03-26 주식회사 엘지생명과학 경구투여 가능한 세팔로스포린계 화합물 및 이의 제조방법
CA2287663C (en) * 1998-11-02 2008-04-08 Isao Kurimoto Process for producing 2-alkylidene-4-bromoacetoacetic acid ester
DE69911348T2 (de) 1998-11-12 2004-07-15 Shionogi & Co., Ltd. Herstellung von Derivaten von 2-Aminothiazol Hydrobromid Z-Isomeren
JP2004512266A (ja) * 2000-06-28 2004-04-22 エルジー・ライフ・サイエンシーズ・リミテッド 新規なセファロスポリン化合物およびその製造方法
KR20020085178A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20020085181A (ko) * 2001-05-07 2002-11-16 주식회사 엘지생명과학 신규 세팔로스포린계 항생제 및 이의 제조 방법
KR20030076759A (ko) * 2002-03-21 2003-09-29 주식회사 엘지생명과학 신규 세팔로스포린 화합물 및 그의 제조 방법
CN1816518A (zh) * 2003-07-10 2006-08-09 先灵公司 由3－酮链烷酸酯制备和纯化2－(烷氧基亚烷基)－3－酮链烷酸酯的方法
RU2277908C1 (ru) * 2005-11-25 2006-06-20 Закрытое акционерное общество "БиоАргоФарм" Водорастворимое средство, обладающее противовирусной активностью, на основе соединения серебра с цистином и способ его получения
CN103193731B (zh) * 2012-01-09 2015-04-22 华东理工大学 一种制备顺式-2-(2-叔丁氧甲酰胺基噻唑-4-基)-2-戊烯酸的方法
CN106831639B (zh) * 2016-12-31 2019-03-19 山东金城柯瑞化学有限公司 头孢卡品侧链酸的制备方法
EP3727673A4 (en) * 2017-12-22 2021-10-27 Illumina Inc. CATALYTIC INGREDIENTS
CN108440442A (zh) * 2018-05-08 2018-08-24 湖北凌晟药业有限公司 一种bapa的合成方法
EP4366295A2 (en) 2018-10-04 2024-05-08 Samsung Electronics Co., Ltd. Method and system for recording a super slow motion video in a portable electronic device
CN111395694A (zh) * 2020-04-09 2020-07-10 安徽扬子地板股份有限公司 一种基于石墨烯的防霉导热地板

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210078A2 (en) * 1985-07-25 1987-01-28 Taisho Pharmaceutical Co. Ltd Cephalosporin derivatives
EP0329457A2 (en) * 1988-02-18 1989-08-23 Taisho Pharmaceutical Co. Ltd Cephalosporin derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1595995A1 (de) * 1966-04-23 1970-02-12 Merck Ag E Fungizides Mittel
US4482565A (en) * 1980-02-22 1984-11-13 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
GB8314803D0 (en) * 1983-05-27 1983-07-06 Hoechst Uk Ltd 7-oxo-4-thia-1 azabicyclo 3.2.0 heptene derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0210078A2 (en) * 1985-07-25 1987-01-28 Taisho Pharmaceutical Co. Ltd Cephalosporin derivatives
EP0329457A2 (en) * 1988-02-18 1989-08-23 Taisho Pharmaceutical Co. Ltd Cephalosporin derivatives

Also Published As

Publication number Publication date
HUT60274A (en) 1992-08-28
DE69103490D1 (de) 1994-09-22
EP0594263B1 (en) 1999-06-09
IE912321A1 (en) 1992-01-29
PT98362B (pt) 1999-01-29
AU634074B2 (en) 1993-02-11
RU2060993C1 (ru) 1996-05-27
DE69103490T2 (de) 1994-12-15
ES2062688T3 (es) 1994-12-16
DE69131325D1 (de) 1999-07-15
CN1058595A (zh) 1992-02-12
FI913458A0 (fi) 1991-07-18
CA2047347A1 (en) 1992-01-20
NZ238838A (en) 1992-08-26
DE69131325T2 (de) 1999-12-02
HU222727B1 (hu) 2003-09-29
US5214037A (en) 1993-05-25
HU912409D0 (en) 1991-12-30
AU8110291A (en) 1992-01-23
KR100203726B1 (ko) 1999-06-15
PH31091A (en) 1998-02-05
FI110322B (fi) 2002-12-31
NO912821L (no) 1992-01-20
EP0467647B1 (en) 1994-08-17
CA2359026A1 (en) 1992-01-20
NO178544B (no) 1996-01-08
FI913458A (fi) 1992-01-20
PL291129A1 (en) 1992-04-06
PL167091B1 (pl) 1995-07-31
PL167119B1 (pl) 1995-07-31
MX9100227A (es) 1993-01-01
JPH0559066A (ja) 1993-03-09
IL98745A0 (en) 1992-07-15
US5352792A (en) 1994-10-04
IE65926B1 (en) 1995-11-29
CA2047347C (en) 2002-03-19
NO912821D0 (no) 1991-07-18
PL167099B1 (en) 1995-07-31
RU2071963C1 (ru) 1997-01-20
NO178544C (no) 1996-04-17
DK0467647T3 (da) 1994-12-05
DK0594263T3 (da) 1999-11-15
ATE181066T1 (de) 1999-06-15
PT98362A (pt) 1992-05-29
JP2618119B2 (ja) 1997-06-11
IL98745A (en) 1997-03-18
EP0467647A2 (en) 1992-01-22
EP0467647A3 (en) 1992-08-12
KR920002609A (ko) 1992-02-28
ATE110081T1 (de) 1994-09-15
EP0594263A1 (en) 1994-04-27

Similar Documents

Publication Publication Date Title
CN1034504C (zh) 硫代烷硫基头孢菌素的制备方法
CN1149874A (zh) 头孢菌素类抗菌素
CN1111410C (zh) 药物组合物的制备方法
CN1046524C (zh) 头孢菌素衍生物
CN1653072A (zh) 广谱的头孢菌素类化合物
CN1129596C (zh) 头孢烯化合物的合成中间体
CN86103619A (zh) 7-取代的双环吡唑烷酮的制备方法
CN1030657C (zh) 抗菌化合物的生产方法
CN1142937C (zh) 抗细菌的头孢菌素
CN1852715A (zh) 头孢类化合物
CN1922190A (zh) 3－吡啶甲基头胞化合物
CN1522259A (zh) 头孢烯类化合物
CN87104995A (zh) β-内酰胺化合物和其制备方法，含该化合物的治疗细菌感染的组合物及合成该化合物的中间产物
CN1052863A (zh) 头孢菌素衍生物的制备方法及其含有头孢菌素衍生物的抗菌剂
CN1050717A (zh) 新颖的头孢菌素衍生物
CN100343260C (zh) 头孢烯化合物
CN1022629C (zh) 新型头孢菌素化合物的制备方法
CN1173979C (zh) 丙烯基头孢茵素衍生物
CN1023801C (zh) 2-氧杂-异头孢烯化合物的制备方法
CN1034940C (zh) 新头孢菌素化合物的制备方法
CN1025195C (zh) 头孢菌素衍生物的制备方法
CN1159809A (zh) 喹诺酮基内酰胺抗微生物化合物和新型的中间体化合物的制备方法
CN1063104A (zh) 三氟甲基1-碳(1-去硫)头孢烯
CN1300290A (zh) 新的头孢菌素化合物,其制备方法及含有它们的抗菌组合物
CN85105120A (zh) 新颖的头孢菌素衍生物类的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee